TITLE

Bayer Schering job cuts

AUTHOR(S)
Williams, Dede
PUB. DATE
March 2007
SOURCE
ICIS Chemical Business;3/5/2007, Vol. 2 Issue 56, p13
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on job cuts at Bayer and Schering. The author states that Schering is set to cut 950 jobs at its former headquarters in Berlin, Germany. The author added that this is due to the merger between the pharmaceutical activities of Schering and Bayer. In relation to this, Bayer chairman Werner Wenning underscored management's commitment to Berlin as its headquarters.
ACCESSION #
24455752

 

Related Articles

  • Too little, too late? Abbot, Alison // Nature;3/30/2006, Vol. 440 Issue 7084, p603 

    The article examines the merger activity in the pharmaceutical industry in Germany. It details Bayer AG's offer to buy Schering AG. According to pharmaceutical analysts, the merger will affect mid-sized drug companies. There are three ways for these companies to respond according to a report...

  • Schering shareholders fight on. Gibson, Jane // ICIS Chemical Business;1/22/2007, Vol. 2 Issue 50, p8 

    The article reports that with a 96.2% majority, Bayer easily squeezed out the remaining Schering shareholders at an extraordinary general meeting. But some, unhappy with the size of the last offered €98.98/share pay out, vowed to sue for higher compensation. A representative of the...

  • Schering Board Accepts Bayer Offer; Private Equity Firms Eye Bayer Units. Alperowicz, Natasha // Chemical Week;4/5/2006, Vol. 168 Issue 12, p18 

    The article reports on the recommendations by the supervisory board of Schering that shareholders accept a takeover offer from Bayer as of March 29, 2006. The deal will increase Bayer's health care sales, making it the 12th-largest health-care group, compared with its current rank of about 20....

  • Bayer Makes Schering Offer Official; Schering Recommends Bid.  // Chemical Week;4/26/2006, Vol. 168 Issue 14, p5 

    The article reports on the official bid price for the acquisition of Schering released by Bayer in April 2006. According to Bayer, there is approximately €3 billion in liquidity available to finance the acquisition. The acquisition would increase the sales of Bayer that were generated by...

  • Bayer Wins Schering. S. H. // Pharmaceutical Executive;Aug2006, Vol. 26 Issue 8, p30 

    The article reports that Bayer AG has acquired the Schering AG. After a long battle with Merck KGaA, the company finally secures enough cash to buy out the share of Merck. Merck had entered into a hostile bid for Schering, but its offer was rejected in favor of Bayer's counterbid. Bayer's bid...

  • Bayer Nears Deal to Purchase Aventis CropScience Joint Venture.  // Chemical Market Reporter;9/10/2001, Vol. 260 Issue 10, p5 

    Reports that Bayer AG is close to reaching an agreement with Aventis and Schering AG for the acquisition of their Aventis CropScience joint venture. Regulations of France on takeovers; Value of the agreement; Investigation of German prosecutors on complaints filed by German patients about...

  • Bayer snags Schering as Merck backs off. Ovrebekk, Hilde // Chemical Market Reporter;6/19/2006, Vol. 269 Issue 24, p6 

    The article reports on the success of Bayer AG to take over German pharmaceutical company Schering after rival Merck KGaA agreed to sell its 21.8 percent stake in the company to create Germany's biggest drug maker. The acquisition was made at an increased price of 89 euros per share. A lengthy...

  • Europe Watch. Robinson, Simon // ICIS Chemical Business;7/17/2006, Vol. 1 Issue 28, p10 

    The article presents an update on issues related to the chemical industry. Bayer was able to own 92.4 percent of Schering after July 6, 2006 closure. German energy group RAG plans to decrease few administrative jobs when it merges the holdings of chemical producer Degussa, power plant operator...

  • International Scene.  // Chemical Business;Jul2006, Vol. 20 Issue 7, p88 

    The article offers news briefs on the chemical industry. The control of a total of 88.0 percent of shares of Schering AG has been gained by Bayer Group. The rights to insecticides discovery pipeline of FMC Corp. were acquired by Bayer CropScience AG.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics